Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byOPKO Health
Date1/2013

General Information

Websitecytochroma.com
CategoryBioTech
Phone847-236-7707
Employees

Offices

Bannockburn, USA
2333 Waukegan Road
Suite E100
Bannockburn, IL, 60015
USA

People

Board Director

Tags

Cytochroma

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.

Recent Milestones

Videos

Screenshots

Sources

  1. OPKO Health to acquire privately held Cytochroma (prnewswire.com) [edit]
Edit This Page
Last Edited 11/12/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy